|
| |
Image Results
Loading...
Loading...
Cangene Patents Pages on BioPortfolio:
|
BioPortfolio News: Reportlinker - Reportlinker Adds World Market ...
24 Sep 2009 ... Review of Marketed Biological Drugs with Expired Patents .... Cangene Corporation. Dr. Reddy's Laboratories Limited ...
http://www.bioportfolio.com/news/Reportlinker_Adds_World_Mar...
|
BioPortfolio Limited Biogenerics, World Market
... Biocon Ltd . BioPartners GmbH; Cangene Corporation; Dr. Reddy's Laboratories Limited ... Table 3-2: Marketed Biopharmaceuticals with Expired Patents ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_233.html...
|
BioPortfolio - Biocorporate Search Plasma1
American Medical Technologies is a patent rich company holding domestic and ... Cangene corporation is a leading Canadian biopharmaceutical company that ...
http://www.bioportfolio.com/biocorporate/Plasma-companies.ht...
|
A biogeneric company leads the field of next generation human ...
Canadian Cangene and partners Apotex and BioGeneriX are still in phase III trials. ... The number of hGH manufacturing companies in countries without
patent ...
http://www.bioportfolio.com/biotech_news/lamerie_4.htm...
|
BioPortfolio Limited The World Market for Biosimilars and the ...
Table 3-1: Select Marketed Biopharmaceuticals with Expired Patents ... Cangene Corporation. Dr. Reddy's Laboratories Limited. Dragon Pharmaceuticals, Inc. ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_2027.html...
|
BioPortfolio - the biotechnology, pharmaceutical, life science and ...
InDepth - Meta-resource pages with description, publications, patents, clinical trials, ... group | t | epicept analys 2009 | cangene europe SITO UFFICIALE ...
http://www.bioportfolio.com/bookshop/SearchIndex/Books/Brows...
|
BioPortfolio - the biotechnology, pharmaceutical, life science and ...
ProtAffin AG Granted Patent in USA For Lead Anti-inflammatory Product PA401 ... InDepth - Meta-resource pages with description, publications, patents, ...
http://www.bioportfolio.com/bookshop/search/Influenza%252BIn...
| Results from other life science and pharmaceutical sites:
Maxygen | News |
7 May 2009 ... Maxygen Announces MAXY-G34 Licensing Arrangement with Cangene for Acute Radiation Syndrome ... Under the agreement, Cangene has paid Maxygen an up-front
fee of $500000. .... Our Platform · Patents · Publications ...
http://www.maxygen.com/newsview.php?listid=318...
|
cd-434309 Patent selection Patent selection Mucke HAM Current ...
Patent selection 1655 AGOURON Novel peptidomimetic derivatives with ... CANGENE RHAMM peptide conjugates for treating diseased organs that contain high ...
http://www.biomedcentral.com/content/download/xml/cd-434309....
|
Betting on biogenerics
Cangene is currently developing its own ver-. Table 1. Countdown on the expiry of patents for selected therapeutic proteins. Brand. Description. Marketer ...
http://www.biotecnol.com/zoom8/upload/15/0338-10Betting.pdf...
|
Treatment of Neutropenia, G-CSF, Neutrophils, Chemotherapy ...
In May 2009, we entered into an option and license agreement with Cangene pursuant to which we have granted Cangene options to obtain certain licenses to
...
http://www.maxygen.com/products-mye.php...
|
Monopoly money : Article : Bioentrepreneur
Patents were originally conceived in the 18th century as a legal tool to encourage .... Meanwhile, companies like Cangene (Winnipeg, MB, Canada) are
already ...
http://www.nature.com/bioent/2003/030101/full/nbt0601supp_BE...
|
Maxygen | News |
In May 2009, Maxygen entered into an agreement with Cangene Corporation pursuant to which Cangene was granted options to obtain certain licenses to intellectual
property rights associated with .... Our Platform · Patents · Publications ...
http://www.maxygen.com/newsview.php?listid=319...
|
Monopoly money
companies like Cangene (Winnipeg, MB,. Canada) are already developing biogenerics for the North American and. European markets. numbers: most of the
patents ...
http://www.biotecnol.com/zoom8/upload/15/0337-9Monopoly.pdf...
|
Report of the Management Board
Cangene Corp., Celltrion, Inc., Gedeon Richter, ... opposing European patents of our competitors as ... patent. These developments further paved the way ...
http://www.crucell.com/annual_report_2008/downloads/Crucell_...
|
Baxter U.S. - 2005 Archived News Releases
September 23, 2005: Baxter Prevails in Sevoflurane Patent Dispute ... April 11, 2005: Baxter and Cangene Announce U.S. FDA Approval of Liquid Formulation of ...
http://www.baxter.com/about_baxter/news_room/news_releases/2...
|
Minimizing Cost and Use of Purified Water
... manufacturing facility for Winnepeg-Canada-based Cangene (www.cangene.com). ... Siemens developed its patent-pending S3 system to reduce energy costs ...
http://www.genengnews.com/articles/chitem_print.aspx?aid=195...
|
|
